Event

Thematic Meeting on Immuno-Oncology




Come discover the latest innovations in Immuno-Oncology !

 

 

Come discover the implemented strategies to transform a target into a therapeutic innovation !

Eurobiomed invites you to its first Thematic Meeting of the year dedicated to the latest innovations in immuno-oncology

Thanks to the participation of key actors of immuno-oncology, this event will be the occasion to browse the development of all of the new immunotherapies ! 

Beyond the hopes aroused by the discovery and the development of new targets, this event will also be the occasion to highlight the collaborative innovations enabling transformation of drug candidates into therapeutic success.

January 23rd 2018,

Timone AP-HM Hospital - Amphitheatre HA2
(264 rue Saint Pierre 13885 Marseille - plan d'accès)

 

Registration Free and mandatory

Program

10h
Welcome of the participants
10h30

Opening  of the Thematic Meeting and Update on Marseille Immunopole

Emilie ROYERE, General Manager - Eurobiomed
Eric VIVIER, Director - Immunology Center of Marseille Luminy
Hervé BRAILLY, Co-founder and Chairman of the Supervisory Board - Innate Pharma
Carine SCHLEWITZ - Chief of Services Technopôles / Innovation - Aix Marseille Provence Métropole

11h

CRCM

Daniel OLIVE, Head of the team  "Immunity and Cancer | Manager of the immune-mentoring CRCM/IPC plateform | Co-founder of ImCheck Therapeutics

11h20

iMAb

Pierre MARTINEAU / Bernaud PAU , Co-founders

11h40

MI-mAbs

François ROMAGNÉ, Scientific Director

12h

OSE Immunotherapeutics

Dominique COSTANTINI, CEO and Director

12h20

Innate Pharma

Mondher MAHJOUBI - Chairman of the Executive Board and CEO

12h40Lunch Break
14h

Servier

Thierry WURCH, Director - External Research and Innovation in Immuno-Oncology

14h20

GamaMabs Pharma

Jean-François PROST, VP - R&D & Strategy
Jean-Marc BARRET, Pharmacology Manager

14h40

Emercell

Amélie CORNILLON, Technical & Scientific Manager

15h

HalioDX

Fabienne HERMITTE, VP Medical Affairs

15h20

AP-HM / RHU PIONeeR

Fabrice BARLESI, Head of the Service Multidisciplinary Oncology and therapeutic innovations

15h40Conclusions

 

 

For more information :  Nicolas Sainte-Foie : nicolas.saintefoie@eurobiomed.org - +33 (0)6 61 78 12 53